Activist Omega Protein investors take aim at Q1 results
An Omega Protein shareholder group who seek a sale of the menhaden catcher over current management's wishes is unhappy with the company's Q1 2016 results
Omega Protein CEO: Fishmeal production costs have stayed stable
Menhaden catcher Omega Protein has seen its costs to produce fishmeal stay stable in recent years, its CEO said, even as demand for the product holds up on stagnant supply
Omega Protein: Company will not be sold, $40m share repurchase planned
The Texas-based menhaden catcher said it will stick with its current strategy instead of selling the fishing business, setting the stage for a battle to change the board
Activist increases stake in Omega Protein, steps up attempt to change board
A large shareholder in menhaden catcher and processor Omega Protein that wants to see a sale of the company is stepping up an attempt to change its board of directors
Shareholder: Omega Protein’s $18m capex plan ‘too little, too late’
An investment fund upset with Omega Protein's management's believes that a planned $18 million capital spend is 'too little, too late' and still wants a sale of the fishing assets
Omega Protein $18m capex to be rolled out in time for 2017 fishing season
US menhaden catcher to make a series of investments over a two-year period, confirmed CEO and president Bret Scholtes
Seeking sale, investor wants board changes at Omega Protein
An activist investor who believes menhaden catcher Omega Protein should leave the supplements business plans to nominate new directors in an effort to encourage a sale
US menhaden fishery management bills shot down
A pair of bills designed to change how menhaden fishing is controlled in the US were shot down in the General Assembly
2015 M&A roundup: Nomad, Cargill lead deal frenzy
Seafood M&A activity in 2015 was marked by mega deals such as Nomad's Iglo and Findus acquisitions and Cargill's purchase of Ewos, but big deals also collapsed
Investor believes Omega Protein changed bylaws to forestall sale
The fight for the future of Omega Protein has intensified with investors accusing the company’s management of changing the firm's bylaws to prevent a forced sale